Skip to main content

Novartis news in 2026: 25 dated events

The latest Novartis event on this page is dated Oct 28, 2026. globenewswire.com reported: Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)

PublicPharmaceutical Manufacturing10,000+ employeesnovartis.comLinkedIn

Get Novartis' live signals in Claude or ChatGPT, or by API

AskWhat changed at Novartis this week? Use Autobound signals for novartis.com.
Dated events
25
Last 90 days
17
Latest
Oct 28, 2026

Source: Autobound Signal API · 77 signals tracked for Novartis · updated

News · latest 10

Latest Novartis news

  1. In development
    Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)Novartis initiated a second Phase 2 clinical study evaluating the VAV1-directed molecular glue degrader MRT-6160 (DDY391) in patients with active moderate to severe psoriatic arthritis.
  2. Revenue
  3. In development
    Kisqali® shows clinically meaningful overall survival in broadest HR+/HER2- early breast cancer population at high risk of recurrenceNovartis announced positive six-year follow-up results from the Phase III NATALEE trial evaluating Kisqali plus endocrine therapy for stage II and III HR+/HER2- early breast cancer.
  4. Partnership
  5. Revenue
    3 steps for taking on Novartis in radiopharma: Curium up firstNovartis generated $1.7 billion in revenue from its radioligand therapies Lutathera and Pluvicto in the first half of the year.
  6. In development
    Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)Novartis's drug Cosentyx® (secukinumab) received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP), recommending it for marketing authorization to treat polymyalgia rheumatica (PMR).
  7. News
  8. Investment
    Novartis strengthens Tyrol as a business location with new investments in KufsteinNovartis has invested approximately 1.8 billion Euro in Austria over the past ten years, strengthening its sites in Kundl and Schaftenau.
  9. Asset sale
    Novartis India Receives Detailed Public Statement for ₹552.49 Crore Open OfferNovartis AG has agreed to sell its 70.68% stake in Novartis India Limited to a consortium led by WaveRise Investments Limited for a total consideration of ₹1,445.89 crore.
  10. In development
    Novartis provides update on delpacibart etedesiran (del-desiran) Phase III HARBOR study for the treatment of myotonic dystrophy type 1 (DM1)Novartis is planning to meet with the FDA to discuss next steps for its delpacibart braxlosiran (del-brax) therapy for facioscapulohumeral muscular dystrophy (FSHD).

Showing 10 of 25 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Novartis with the Signal API

One POST /v1/companies/enrich call with novartis.com returns Novartis news signals (news), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"novartis.com","signal_types":["news"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.

Talk to sales

Same industry

Questions about Novartis news

What is the latest news on Novartis?
The newest event on this page is dated Oct 28, 2026. globenewswire.com reported: Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391). This page lists 25 dated events for Novartis, each with a source link.
What is going on with Novartis?
The 10 latest events on this page cover in development (4), revenue (2), partnership (1), news (1), investment (1) and asset sale (1). The newest: Oct 28, 2026: Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391) (globenewswire.com).
Is Novartis laying off employees?
2 layoff events were reported for Novartis. The latest: Sep 2, 2026: Novartis cuts 130 jobs in Basel: Biologics production in Kleinbasel to be abandoned (bazonline.ch). See the Novartis layoffs page for the dated list.

Page updated , the date of the newest row on this page.

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →